06:28 AM EDT, 10/17/2024 (MT Newswires) -- Elevance Health ( ELV ) reported Q3 adjusted earnings Thursday of $8.37 per diluted share, down from $8.99 a year earlier.

Analysts polled by Capital IQ expected $9.65.

Operating revenue for the quarter ended Sept. 30 was $44.72 billion, compared with $42.48 billion a year earlier.

Analysts surveyed by Capital IQ expected $43.14 billion.

The company said it now expects 2024 adjusted EPS of about $33, down from $37.20 anticipated previously. Analysts polled by Capital IQ expect $37.25.

Meanwhile, the company maintained a quarterly dividend of $1.63 per share, payable Dec. 20 to shareholders of record on Dec. 5.

Elevance Health's ( ELV ) share price dropped over 11% in recent Thursday premarket activity.

Price: 440.00, Change: -56.96, Percent Change: -11.46